Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Current Deferred Revenue (2023 - 2025)

Haoxi Health Technology has reported Current Deferred Revenue over the past 3 years, most recently at $537646.0 for Q2 2025.

  • Quarterly results put Current Deferred Revenue at $537646.0 for Q2 2025, down 54.63% from a year ago — trailing twelve months through Jun 2025 was $537646.0 (down 54.63% YoY), and the annual figure for FY2025 was $537646.0, down 54.63%.
  • Current Deferred Revenue for Q2 2025 was $537646.0 at Haoxi Health Technology, down from $1.2 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for HAO hit a ceiling of $1.5 million in Q2 2023 and a floor of $537646.0 in Q2 2025.
  • Median Current Deferred Revenue over the past 3 years was $1.2 million (2024), compared with a mean of $1.1 million.
  • Biggest five-year swings in Current Deferred Revenue: decreased 20.67% in 2024 and later plummeted 54.63% in 2025.
  • Haoxi Health Technology's Current Deferred Revenue stood at $1.5 million in 2023, then decreased by 20.67% to $1.2 million in 2024, then tumbled by 54.63% to $537646.0 in 2025.
  • The last three reported values for Current Deferred Revenue were $537646.0 (Q2 2025), $1.2 million (Q2 2024), and $1.5 million (Q2 2023) per Business Quant data.